简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2024-09-10 10:51 Novotech Unveils 2024 Report on Global Gastric Cancer Clinical Trials and Cutting-Edge Therapeutics
2024-09-06 17:38 Novotech Releases 2024 Report on Pancreatic Cancer Clinical Trials and Drug Development
2024-09-05 15:30 Rapid Medical™ Reports No Safety Concerns for Medium Vessel Occlusions in the Interim Safety Analysis of the DISTALS Study with TIGERTRIEVER™13
2024-09-05 15:12 PHC Launches LiCellMoTM Live Cell Metabolic Analyzer for Real-Time Visualization of Cellular Metabolism in Cell and Gene Therapies
2024-09-05 15:02 Avania Appoints Recognized CRO and MedTech Industry Leader, Jason Monteleone, as New President and CEO
2024-09-05 13:48 Transforming the Future of Medicine with RNA-Based Therapies
2024-09-04 18:21 HistoSonics® Publishes Results of its Pivotal #HOPE4LIVER Trials
2024-09-02 12:30 Kaneka Completes Construction of Medical Device Plant in Hokkaido
2024-08-30 08:01 Merck Announces First Patient Dosed in Phase III Study of Oral Cladribine in Generalized Myasthenia Gravis (gMG)
2024-08-29 14:38 Galderma Successfully Issued an Inaugural CHF 500 Million Bond
2024-08-29 13:12 HistoSonics™ Partners with Li Ka Shing Foundation to Launch First Histotripsy Programs in Hong Kong
2024-08-29 12:44 Novotech Earns Renewed Certification as an Employer of Choice for Gender Equality
2024-08-28 16:56 Lubrizol Opens Beauty Research Institute in Shanghai, China
2024-08-26 11:06 European Commission approves Celltrion’s SteQeyma® (CT-P43), a biosimilar to Stelara® (ustekinumab), for the treatment of multiple chronic inflammatory diseases
2024-08-26 11:02 HemoHim's Global Market Success Rooted in Rigorous Quality Control
2024-08-23 13:11 PCI Pharma Services’ Bedford, New Hampshire Location Successfully Completes International Coalition of Medicines Regulatory Authorities Inspection
2024-08-22 08:24 Innovo Therapeutics Inc. Announces Phase 2 Clinical Results Demonstrating the Innovative Efficacy of INV-001 for the Treatment of Post-thyroidectomy Scars
2024-08-21 10:47 Organon & Lilly Expand Migraine Commercialization Agreement to 11 Additional Markets
2024-08-20 11:35 Guard Medical Announces FDA 510(k) Clearance for Additional Large Sizes of Its Novel NPseal® NPWT Surgical Dressing, Unlocking the Orthopedic Market
2024-08-13 13:08 Galderma Receives U.S. FDA Approval for Nemluvio® (nemolizumab) for Adult Patients Living With Prurigo Nodularis

Business Wire Weibo

Press Releases

Latest Releases